Company news
GoodRx Holdings, Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
GoodRx Report Shows Millions at Risk as Endocrinologist Shortages Hit Nearly 70% of U.S. Counties
December 16, 2024
GoodRx Appoints Healthcare Industry Veteran, Wendy Barnes, as New Chief Executive Officer
December 15, 2024
GoodRx Reveals Americans Overspent on Weight Loss Medications by $200 Million This Year, Fills Still Surged
December 4, 2024
GoodRx Reports Third Quarter 2024 Results
November 6, 2024
GoodRx to Participate in Upcoming Investor Conferences
November 3, 2024
GoodRx Unveils New E-commerce Platform, Launches with Opill®
October 30, 2024
GoodRx Announces Exclusive Low Cash Price for QSYMIA®, the Leading Branded Once-Daily Oral Weight Management Medication for Adults
October 28, 2024
Ronald E. Bruehlman Joins GoodRx Board of Directors
October 27, 2024
GoodRx Announces New Affordability Programs for Menopause Hormone Therapies
October 22, 2024
GoodRx Partnering with Retail Pharmacies to Deliver Pay-Over-Time Option Directly to Consumers
October 15, 2024
GoodRx Announces Date for Third Quarter 2024 Earnings Release and Conference Call
October 9, 2024
GoodRx Announces Lowest Discounted Cash Price at Retail Pharmacy Locations for neffy® (epinephrine nasal spray)
September 25, 2024
GoodRx Reports Second Quarter 2024 Results
August 7, 2024
Boehringer Ingelheim and GoodRx announce exclusive patient affordability initiative for Adalimumab-adbm injection, Boehringer's biosimilar to Humira®
July 17, 2024
GoodRx Announces Date for Second Quarter 2024 Earnings Release and Conference Call
July 10, 2024
Ian T. Clark Joins GoodRx Board of Directors
July 9, 2024
GoodRx Launches New “Prescription Cost Tracker” to Spotlight Key Factors Driving Out-of-Pocket Medication Costs in the U.S.
June 25, 2024
Simon Patterson Joins GoodRx Board of Directors
May 29, 2024
GoodRx Named One of the 2024 TIME100 Most Influential Companies
May 29, 2024
GoodRx Offers Discounts of Up to 43% On Fertility Treatments
May 21, 2024
GoodRx and Kroger Sign Direct Contracting Agreement
May 14, 2024
GoodRx Reports First Quarter 2024 Results
May 8, 2024
GoodRx Announces Date for 2024 Investor Day
April 23, 2024
GoodRx Announces Date for First Quarter 2024 Earnings Release and Conference Call
April 10, 2024
GoodRx Interim CEO Extends Commitment to Company
March 13, 2024
GoodRx Reports Fourth Quarter and Full Year 2023 Results
February 28, 2024
GoodRx Announces Date for Fourth Quarter and Full Year 2023 Earnings Release and Conference Call
January 31, 2024
GoodRx Announces Proposed Refinancing of First Lien Credit Facilities
January 21, 2024
The GoodRx Effect: Delivering a Transformative Impact on the U.S. Healthcare System through Prescription Savings
January 10, 2024
GoodRx Announces Preliminary Fourth Quarter and Full Year 2023 Results and Early Expectations for First Quarter and Full Year 2024
January 9, 2024
GoodRx Appoints Kelly J. Kennedy to Board of Directors
December 21, 2023
GoodRx to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
December 12, 2023
GoodRx to Participate in the Evercore ISI HealthCONx Conference
November 15, 2023
GoodRx Reports Third Quarter 2023 Results
November 8, 2023
GoodRx Announces New Way for Consumers to Access Sanofi’s Lantus for $35 at Over 70,000 Pharmacies Nationwide
October 18, 2023
GoodRx Announces Date for Third Quarter 2023 Earnings Release and Conference Call
October 11, 2023
GoodRx and Navitus Health Solutions Announce Savings Connect Program to Deliver Lower Prescription Prices for Navitus Members
October 11, 2023
GoodRx Announces Significant Savings on Antivirals, Medications and Vaccines for Cold & Flu Season
September 20, 2023
GoodRx and MedImpact Announce Program to Ensure Seamless Access to Affordable Prescriptions
September 12, 2023
GoodRx Now Offers 40% More Savings on Nearly 200 Medications at Walgreens
September 10, 2023
GoodRx to Present at the Morgan Stanley Global Healthcare Conference
August 29, 2023
GoodRx Launches Real-Time Benefit Check In Provider Mode To Offer Comprehensive Cost Information At The Point of Prescribing
August 29, 2023
GoodRx Reports Second Quarter 2023 Results
August 8, 2023
GoodRx Unveils Medicine Cabinet, A Better Way To Manage All Of Your Prescriptions
July 26, 2023
GoodRx Announces Date for Second Quarter 2023 Earnings Release and Conference Call
July 11, 2023
CVS Caremark and GoodRx to launch Caremark® Cost Saver™ to help lower out-of-pocket drug costs for CVS Caremark clients' members
July 11, 2023
GoodRx Appoints Dorothy Gemmell as Chief Commercial Officer
July 9, 2023
GoodRx to Present at the Jefferies Healthcare Conference
May 24, 2023
GoodRx Reports First Quarter 2023 Results
May 9, 2023
GoodRx to Present at the BofA Securities 2023 Health Care Conference
April 26, 2023
Calls
The 5 newest of 24 calls. Every call is listed under its year.
- GoodRx Holdings (NASDAQ:GDRX) Q2 2026 Earnings Call
Aug 6, 2026
Transcript - GoodRx Holdings (NASDAQ:GDRX) Q1 2026 Earnings Call
May 7, 2026
Transcript - GoodRx Holdings (NASDAQ:GDRX) Q4 2025 Earnings Call
Feb 26, 2026
Transcript - GoodRx Holdings (NASDAQ:GDRX) Q3 2025 Earnings Call
Nov 5, 2025
Transcript - GoodRx Holdings (NASDAQ:GDRX) Q2 2025 Earnings Call
Aug 7, 2025
Transcript
Decks
- Q4 2025 Earnings Presentation
Earnings · 27 slides · Feb 26, 2026
- Q3 2023 Earnings Presentation
Earnings · 25 slides · Nov 9, 2023
- Q2 2023 Earnings Presentation
Earnings · 24 slides · Aug 9, 2023
- Q1 2023 Earnings Presentation
Earnings · 27 slides · May 10, 2023
- Q4 2022 Earnings Presentation
Earnings · 29 slides · Feb 28, 2023